Smooth muscle aldolase C-bound inositol 1,4,5-trisphosphate studied in vitro under physiological conditions  by Baron, Carl B et al.
 .Biochimica et Biophysica Acta 1401 1998 81–92
Smooth muscle aldolase C-bound inositol 1,4,5-trisphosphate studied in
vitro under physiological conditions
Carl B. Baron ), Parmatma Greeley, Ronald F. Coburn
From the Department of Physiology, Uni˝ersity of Pennsyl˝ania School of Medicine, Philadelphia, PA, USA
Received 6 June 1997; accepted 8 September 1997
Abstract
  . .  .Our goal was to quantitate inositol 1,4,5-trisphosphate Ins 1,4,5 P binding to aldolase C tetramer aldolase and its3 4
  . .displacement by inositol 1,3,4-trisphosphate Ins 1,3,4 P under conditions which approximated the in vivo state. Anions3
w x  .were found to have major effects. Decreasing KCl from 100 to 10 mM, at 08C and pH 7.0, increased maximal Ins 1,4,5 P3
w yxbinding to 1.0 to 2.4 mol per mol aldolase . At 10 and 30 mEqrl Cl , an additional high affinity site was detected4
 .  2y y y y.K ss0.43 and 0.86 mM, respectively . Increasing concentrations of other anions SO , propanoate , HCO , acetated 4 3
also inhibited binding, but effects would be minimal at concentrations of these anions present in the cytoplasm of living
 .  . w yx w yxcells. Ins 1,3,4 P displacement of aldolase C-bound Ins 1,4,5 P was sensitive to Cl ; at 30 mEqrl Cl and 378C,3 3
 .  .Ins 1,3,4 P released 20% of bound Ins 1,4,5 P at concentrations of 100 nM. Changing temperature from 08 to 378C3 3
 . w 2qx w 2qx w qx w qxincreased K s for Ins 1,4,5 P binding. Changes in free Ca , Mg , Na and K and changes in osmolality had nod 3
 .  . w yxeffect on Ins 1,4,5 P binding to aldolase C. In vivo Ins 1,4,5 P –aldolase binding at 30 mEqrl Cl and 378C were3 3 4
w  . x w  . xcalculated for different Ins 1,4,5 P over the range 0.2 to 1.0 mM. For different cytoplasmic Ins 1,4,5 P ,3 free 3 free
 . w  . xIns 1,4,5 P binding to aldolase was sufficient, if acutely released, to nearly double cytoplasmic Ins 1,4,5 P . We3 4 3 free
 .  .proposed a schema whereby release of aldolase C-bound Ins 1,4,5 P evoked by Ins 1,3,4 P amplifies effects of3 3
 .phospholipase C-formed Ins 1,4,5 P . q 1998 Elsevier Science B.V.3
Keywords: Aldolase C; Inositol 1,4,5-trisphosphate; Smooth muscle; Chloride; Temperature; Inositol 1,3,4-trisphosphate
1. Introduction
In unstimulated porcine trachealis smooth muscle
 .PTSM , the tissue inositol 1,4,5-trisphosphate
  . .Ins 1,4,5 P content was 13.3 pmolr100 nmol lipid3
Pi which was equivalent to an intracellular concentra-
tion of 2.7 mM, if it were mixed in total cellular
w xwater 1 . This is a value in excess of that needed for
2q  .  .Ca release via Ins 1,4,5 P -receptors IP R present3 3
 .in endoplasmic and sarcoplasmic reticulum ERrSR
)  .Corresponding author. Fax: q1 215 573-5851; E-mail:
cbaron@mail.med.upenn.edu
w x  .2–5 . A similar Ins 1,4,5 P content was measured3
in another unstimulated smooth muscle, the rabbit
w x  .aortic smooth muscle 6,7 . High Ins 1,4,5 P con-3
tents have been detected in other unstimulated cells
w xand tissues as previously summarized 1 .
 .Ins 1,4,5 P present in unstimulated PTSM did not3
w xhave access to degrading enzymes 1 as indicated by
 .the absence of Ins 1,4,5 P by-products in the tissue.3
 .Carbachol CARB -evoked contraction of PTSM was
 .associated with large increases in Ins 1,4,5 P forma-3
tion and degradation, but without increases in total
 . w xIns 1,4,5 P content 1,8 . Following atropine-in-3
duced relaxation of a CARB-evoked contraction, there
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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 .was a rapid 40% decrease in total Ins 1,4,5 P con-3
w xtent 8 and accompanying decreases in contents of
 . w xIns 1,4,5 P by-products 1 . The above data were3
consistent with the presence of both bound and free
 .Ins 1,4,5 P in unstimulated and stimulated PTSM.3
 .Since the total Ins 1,4,5 P content did not increase3
during CARB stimulation, increases in free
w  . x w  . x .Ins 1,4,5 P Ins 1,4,5 P required to released3 3 free
SR Ca2q must have been associated with a decrease
 .in bound or sequestered Ins 1,4,5 P . A decrease in3
 .total muscle Ins 1,4,5 P content, following rapid3
inhibition of contraction, was consistent with a de-
w  . xcrease in Ins 1,4,5 P and a decrease in bound or3 free
 .sequestered Ins 1,4,5 P content.3
 .Two classes of soluble Ins 1,4,5 P binding pro-3
w xteins have been identified; aldolases 9,10 and com-
 .pounds which contain pleckstrin homology PH do-
 . wmains studied using phospholipase C PLC -d 11–1
x  .17 . Ins 1,4,5 P binding to aldolase A and B was3
w xdiscovered by Koppitz et al. 10 . Following these
data, we isolated and purified aldolase from the
cytoskeleton of PTSM, determined it to be aldolase
C, and, by assay, characterized aldolase C–
 . w xIns 1,4,5 P binding 9 . Like the case for aldolase A3
 .and B, bound Ins 1,4,5 P could be released by the3
 .aldolase substrate Fru 1,6 P . In addition, it was re-2
  . .leased by inositol 1,3,4-trisphosphate Ins 1,3,4 P .3
 .Although the K for Ins 1,4,5 P binding was highd 3
 w xunder conditions used in this study i.e. KCl 100 mM
.at 08C , the total quantity of cellular aldolase avail-
 .able for Ins 1,4,5 P binding was large suggesting3
 .there might be physiologically significant Ins 1,4,5 P3
binding to aldolase in intact muscle. Whether PLC-d1
 .binds significant Ins 1,4,5 P in intact cells is depen-3
dent on cellular PLC-d content, which so far, to our1
knowledge, has not been estimated in any cell type;
also cytosolic extracts have only one-twentieth the
w xbinding capacity of the partially purified PLC-d 11 .1
Our goal in this study was to quantitate
w  . x  .Ins 1,4,5 P –aldolase C-bound Ins 1,4,5 P rela-3 free 3
tionships under conditions that are applicable to the
intracellular environment of intact muscle. We wanted
to determine if significant binding occurs under this
w xcondition. Since both anion and temperature influ-
w  . x  .enced Ins 1,4,5 P –aldolase C-bound Ins 1,4,5 P3 free 3
plots, we studied effects of both of these variables.
We assessed the significance of the extent of
 .Ins 1,4,5 P binding to aldolase C determined under3
‘‘physiological’’ conditions by computing effects of
 .a complete release of bound Ins 1,4,5 P on cytosolic3
w  . xIns 1,4,5 P .3 free
2. Materials and methods
2.1. Preparation of porcine tracheal smooth muscle
aldolase and measurement of enzyme acti˝ity
w xEnzyme was prepared as previously described 9
with the following modification. Aldolase-containing
fractions of the DEAE wash-through were applied to
w x  w a 1 ml column of a204 resin 18 2-O- 4- 5-
. xaminoethyl-2-hydroxyphenylazo benzoyl -1,4,5-tri-
.O -phosphono-m yo-inosito l-Sepharose 4B
  . .Ins 1,4,5 P -affinity column . This column was3
washed with about 24 ml of Standard Buffer 20 mM
 .Hepes–Na pH 7.0 , 20 mM KCl, 1 mM N-hydroxy-
 .ethylethylenediamine triacetic acid HEDTA and
.0.1 mM dithiothreitol and then with about 20 ml of
Standard Buffer containing an additional 80 mM KCl
 w x .total KCl s100 mM . Aldolase was then eluted
from the column with 5 mM fructose 1,6-bisphos-
  . .phate Fru 1,6 P in Standard Bufferq80 mM KCl2
and then dialyzed against Standard Buffer to remove
 .Fru 1,6 P .2
Activity was assayed at 378C as previously de-
w x  . scribed 9 with 200 mM triethanolamine TEA pH
.7.6 , 10 mM ethylethylenediamine tetraacetic acid
 .  .EDTA , 2 mM Na AsO , 1 mM Fru 1,6 P and 12 4 2
unit rabbit skeletal muscle D-glyceraldehyde 3-phos-
 .phate dehydrogenase GAPDH in 1 ml by monitor-
ing NADH formation at 340 nm.
( )2.2. Ins 1,4,5 P binding assay3
This assay utilized protein precipitation with poly-
 . w xethylene glycol PEG 9,12 . This assay has previ-
ously been shown to give the same binding data as
w xdetermined using an equilibrium dialysis method 9 .
The PEG method was identical to that used previ-
ously, except the buffer used was 50 mM Hepes–Na,
pH 7.0. Each assay contained approximately 0.004
 .units of aldolase about 1.2 mg . For every test sam-
ple there was a corresponding blank and the differ-
ence in radioactivity in the absence and presence of
 .aldolase i.e. 30 mg g-globulin"1.2 mg aldolase
w xwas determined. In assays where KCl was kept low,
30 mM imidazole-propanoate the name approved by
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the International Union of Chemists over ‘‘pro-
.pionate’’ , pH 7.0, was substituted for 50 mM
Hepes–Na, pH 7.0. For binding measurements at 08
and 378C, all procedures in the assay were done at
the specified temperature. Fractions of aldolase pre-
cipitated by the PEG assay at 08 and 378C were
w xdetermined as previously described 9 and found to
be 0.753"0.009 and 0.775"0.012, respectively. In
w 2qxexperiments where effects of changing free Ca
were examined, KCl was maintained at 50 mM and
Ca2q was buffered with 1 mM EDTA for pCa from
7–9 and with 1 mM HEDTA for pCa from 4–6.
Levels of total Ca2q were determined by using the
w xprogram MAXC, v6.50 19 . We determined effects
2q  .of free Mg on Ins 1,4,5 P binding to aldolase C3
by comparing data at 0 and 1.0 mM. The effect of
w yxHCO was tested using stock solutions prepared3
using different methods for the purpose of pH and
w yx  .HCO maintenance during the assay: 1 0.5 M3
NaHCO was adjusted to pH 7.0 by addition of3
 .  .propanoic acid 0.118 mM or 2 by bubbling CO2
into a solution of KHCO until the pH was 7.03
 .  .stocks were: 0.5 M at 08C and 0.05 M at 378C . 3
Each sample was covered with 0.4 ml of paraffin oil
and then aliquots of 0.5 M KHCO and then PEG,3
were injected through the oil phase so that the assay
was performed without exposing the aqueous solution
to air. Data obtained with these approaches produced
the same results.
( )2.3. Ins 1,3,4 P e˝oked release of aldolase C bound3( )Ins 1,4,5 P3
w3 x  .Release of bound H -Ins 1,4,5 P was measured3
using the binding assay described above. As above,
for every test sample there was a corresponding blank
and the difference in radioactivity in the absence and
presence of aldolase i.e. 30 mg g-globulin"1.2 mg
.aldolase was determined at each concentration of
 .Ins 1,3,4 P tested.3
2.4. Cur˝e fitting
Constants and standard errors were obtained by
using non-linear curve fitting with the computer pro-
 .gram SYSTAT ver. 3.0 using data at all concentra-
tions. This program gave the values" the standard
error for each constant in the equation used for the
fit. Sigmoidal curves were fitted to the general equa-
 .   . b.tion ys ayc r 1q xrk qc where ‘‘a’’ was
 .sets100% i.e. maximum binding and ‘‘c’’, if-0,
w xwas sets0 20 .
2.5. Materials
w3 x  .H -Ins 1,4,5 P was purchased from Dupont3
 .NEN, Wilmington, DE. Non-radioactive Ins 1,4,5 P3
was from American Radiolabeled, St. Louis, MO.
 .Hepes, imidazole, polyethylene glycol 8000 , g-
globulins, EDTA, HEDTA, DL-glyceraldehyde 3-
 .phosphate GAP , dihydroxyacetone phosphate
 .  . DHAP , NAD, Ins 1,3,4 P , arsenic acid disodium3
.  .  .  .salt , Fru 1,6 P , fructose 6 P, glucose 6 P and glu-2
 .cose 1 P were from Sigma, St. Louis, MO. Rabbit
skeletal muscle GAPDH, was from Boehringer
Mannheim, Indianapolis, IN. All other chemicals were
reagent grade.
3. Results
3.1. Effect of Cl y and other anions on binding of
( )Ins 1,4,5 P to aldolase C at 08C.3
 .Ins 1,4,5 P binding to aldolase C was found to be3
w xmarkedly increased by decreasing KCl in the assay
media. Data obtained at 08C are given in Fig. 1. This
effect can also be seen in Fig. 2, where it is shown
w xthat decreasing KCl from 100 to 10 mM increased
w  . xbinding at a given Ins 1,4,5 P . The magnitude of3 free
w  . x this effect was greatest at low Ins 1,4,5 P i.e.3 free
. w yx-0.1 mM where decreasing Cl from 100 to
 .10 mEqrl resulted in up to 29 times more Ins 1,4,5 P3
w xbinding; decreasing KCl from 100 to 30 mEqrl
 .resulted in up to 7 times more Ins 1,4,5 P binding to3
aldolase C the values for this comparison were
obtained by dividing the 10 mM KCl fitted curve or
the 30 mM KCl fitted curve by the 100 mM KCl
.fitted curve .
Binding was identical in NaCl and KCl experi-
ments. Sucrose substitution experiments determined
 .that the KCl sensitivity of Ins 1,4,5 P binding to3
 .aldolase was not due to osmolality data not shown .
 .Comparisons of KCl, choline chloride CholineCl
 . and the K salt of propanoic acid KPropanoate Fig.
.  .1 indicated that Ins 1,4,5 P binding to aldolase C3
was decreased by both anions, but that, at equivalent
concentrations, Cly exerted a greater inhibitory effect
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 .Fig. 1. Anion and cation effects on binding of Ins 1,4,5 P to3
aldolase at 08C. All data were fit to the sigmoidal equation
.  .  .described in Section 2 lines : KCl ‘, ns37 ; KPropanoate
 .  .  . . I, ns43 ; CholineCl =, ns30 and Na or K HCO \, n3
.  . w x w xs52 . % Ins 1,4,5 P bound at low KCl , KPropanoate ,3
w x w x w xCholineCl , NaHCO or KHCO was set at 100% to facilitate3 3
comparisons. Error bars"SEM.
than did propanoatey. This finding was extended to
other anions keeping their concentrations at 100
 .mEqrl: at 08C; inhibition of Ins 1,4,5 P binding was3
largest with SO2y )HCOy)Cly)propanoateys4 3
acetatey, 0.01:0.11:0.23:0.40, respectively, of values
determined using 10 mM KCl.
[ y]3.2. Decreasing Cl recruits a high affinity
( )Ins 1,4,5 P binding site on aldolase C.3
 .Aldolase–Ins 1,4,5 P binding data obtained previ-3
ously at 100 mM KCl at 08C fit closely to a one site
model using the equation for the dissociation con-
stant, giving a K value of 13.6 mM and maximald
 .binding corresponding to one mol Ins 1,4,5 P per3
w xmol of aldolase 9 . Data obtained at 10 and4
w yx30 mEqrl Cl at 08C did not fit to the one site
model and so were analyzed using a two site model
 . w xFig. 2 21 . This model, which assumed aldolase
 .contained two independent sites for Ins 1,4,5 P bind-3
w  . x w x Fig. 2. Ins 1,4,5 P -bound aldolase C plots obtained at different KCl at 08C. Binding data were fit to the two site model described3 free
. in the text . Data designated ‘‘10 mM KCl’’ are given as ‘ and solid lines, ns49. 10 mM is a mean value; data were obtained over the
.  .range 2–13 mM KCl . Binding data at 30 mM KCl are given as ^ and long dashed lines ns34 . The short dashed line indicates data
w xpreviously published 9 using 100 mM KCl and a one site model. Dissociation constants, K and K , and numbers of binding sites, nd1 d2 1
 .and n , are given in Table 1. The log–log presentation right is shown for ease of visualization of all data obtained.2
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Table 1
w yx  .Effect of Cl on the characteristics of Ins 1,4,5 P binding to3
aldolase at 08C and pH 7.04
y aw xCl K K n nd1 d2 1 2
 .  .  .mEqrl mM mM
10 0.43"0.17 7.4"2.4 0.75"0.22 1.99"0.15
30 0.86"0.48 30.7"5.8 0.34"0.10 1.65"0.09
100 14.4"1.1 y 1.00"0.04 y
a K shigh affinity site; K s low affinity site; n and n ared1 d2 1 2
 .number of moles Ins 1,4,5 P bound on each site per mol al-3
dolase . All data were obtained using at least 34 points and4
w xequations given in the text. Data obtained at 100mM KCl were
computed using a one site model; data obtained at 30 and 10 mM
w xKCl were computed using a two site model. Errors were
determined by the curve fitting program, SYSTAT.
ing, is described below:
rs n C rK r 1qC rK .  .1 S d1 S d1
q n C rK r 1qC rK .  .2 S d2 S d2
where rs‘‘molar ratio of the amount of ligand
bound to the total amount of acceptor’’, n and1
n s‘‘the respective numbers of acceptor sites’’, C2 S
s‘‘the concentration of free ligand’’, K s‘‘the in-d
trinsic dissociation constant’’. Values of n , n , K1 2 d1
and K were generated by using all data points.d2
Table 1 compares these characteristics of binding at
w yx100, 30 and 10 mEqrl Cl . These data indicated
w yxthat decreasing Cl from 100 to 30 or 10 mEqrl
recruited a high affinity site which had a 15 to
 .30-fold higher affinity for Ins 1,4,5 P binding than3
the low affinity site. K of the high affinity sitesd
during 10 and 30 mEqrl Cly were 0.43 and 0.86 mM,
respectively. The addition of this site increased stoi-
chiometry for binding from 1 mol per mol aldolase4
 .to about 3 mol per mol aldolase n qn . Mean K4 1 2 d
and n values given in Table 1 were obtained using
curve analysis of data obtained from at least 3 differ-
ent experiments and we could not compute P values
for comparison of K and n values determined atd
w yxdifferent Cl . We do have SEM values computed
w  . x w yxFig. 3. Ins 1,4,5 P -bound aldolase C plots using data obtained at 10 and 30 mEqrl Cl at 08 and 378C. Data were plotted over the3 free
w  . xestimated physiological range for Ins 1,4,5 P . Curves were determined by fitting all the data to the two site model. All data are also3 free
given as log–log plots in the insets.
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Table 2
 .Effect of temperature on characteristics of Ins 1,4,5 P binding to3
aldolase4
yw x  .  .Cl 8C K mM K mM n nd1 d2 1 2
 .mEqrl
10 0 0.43"0.17 7.4"2.4 0.75"0.22 1.99"0.15
10 37 2.74"0.88 42.0"0.13 1.05"0.30 1.71"0.78
30 0 0.86"0.48 30.7"5.8 0.34"0.10 1.65"0.09
30 37 1.09"0.41 52.0"0.1 0.19"0.04 0.75"0.14
w yx Temperature data are given for two different Cl some of the
data are also in Table 1, but are shown here for direct compar-
.isons . Insignia are the same as in Table 1. Data were computed
using equations given in the text using the two site model at
.least 19 data points per calculation . Errors were determined by
the curve fitting program, SYSTAT.
from dispersion of points. Although data clearly show
recruitment of a high affinity binding site and in-
w yxcrease in total binding at low Cl , we could not
convincingly show differences in either K or nd
values comparing 10 and 30 mEqrl data.
( )3.3. Effect of altering temperature on Ins 1,4,5 P3
binding to aldolase C
Fig. 3 shows effects of changing temperature on
w  . x  .Ins 1,4,5 P –aldolase C-bound Ins 1,4,5 P plots.3 free 3
w yxData at 08 and 378C are given for two different Cl ,
10 and 30 mEqrl. The characteristics of binding are
given in Table 2. These data indicate that at 10 mEqrl
Cly, increases in temperature decreased the affinity
of both binding sites without an effect on n or n .1 2
We could not show, based on comparisons of means
"SEM, an effect of temperature on either K ord1
K or n or n at 30 mEqrl Cly.d2 1 2
w yxAt 08C increasing HCO markedly inhibited al-3
 .  .dolase C–Ins 1,4,5 P binding Fig. 1 , whereas at3
w yx378C no effect of increasing HCO to about3
 .20 mEqrl was detectable Fig. 4 .
w yx  . y w yxFig. 4. Effect of HCO on aldolase–Ins 1,4,5 P binding at 378C. The HCO samples were all done with a Cl of 3.2 mEqrl; the3 3 3
y  y y  .samples with Cl alone were in the range of 3.2–23.2 mEqrl HCO and Cl mEqrl for each point mean of 3 assays"SEM are
. y yshown above and below each data point in the figure . I indicates results of assays performed with both Cl and HCO present. =3
y y  . w yxindicates control data where Cl was present and HCO absent. Ins 1,4,5 P binding is normalized to that determined for a Cl3 3
3.2 mEqrl in the absence of HCOy. Lines are based on sigmoidal fits.3
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[ y] ( )3.4. Effect of Cl on Ins 1,3,4 P -e˝oked release of3( )aldolase C-bound Ins 1,4,5 P3
 .Like the case with Ins 1,4,5 P binding to aldolase3
 .  .C, Ins 1,3,4 P -evoked Ins 1,4,5 P release was also3 3
w yx  .markedly sensitive to changes in Cl . Fig. 5 A
w yx  .compares effect of changes in Cl at 08C. Fig. 5 B
 .  .shows Ins 1,3,4 P -evoked Ins 1,4,5 P displacements3 3
y  .at 378C and 30 mEqrl Cl . Ins 1,3,4 P -evoked re-3
 . w  . xlease of bound Ins 1,4,5 P occurred at Ins 1,3,4 P3 3
 .-1 mM. EC values in mM for displacement of50
 .Ins 1,4,5 P under the three conditions described are:3
 . 5.4"2.0 100 mM KCl, 08 , 0.56"0.06 10 mM
.  .KCl, 08 , and 0.44"0.09 30 mM KCl, 378 .
[ y]3.5. Effect of Cl on inhibition of aldolase C
( ) ( )Ins 1,4,5 P binding e˝oked by Fru 1,6 P , glycer-3 2( )aldehyde-3-phosphate GAP and dihydroxyacetone
( )phosphate DHAP
 .These data were all obtained at 08C. Fru 1,6 P2
 .was 8-fold more effective in releasing Ins 1,4,5 P at3
w xlow KCl than originally found at 100 mM KCl 9
  .the EC for release was 3.7"0.5 mM ns15 at50
2 mM KCl versus 30"5 mM at 100 mM KCl. At
w3 x10 mM KCl, DHAP displaced aldolase C-bound H -
 . w x Ins 1,4,5 P at a lower DHAP EC s17"1 mM,3 50
. ns15 than determined at 100 mM KCl EC s4650
."5mM, ns18 . There was no difference in the
w3 x  .EC for H -Ins 1,4,5 P displacement by GAP at50 3
  .100 versus 10 mM KCl 17"3 ns15 versus 16"
 . .2 ns18 mM .
3.6. Effects of negati˝ely charged phosphates on
( )Ins 1,4,5 P binding to aldolase C3
Studies were performed at 08C and 100 mM KCl.
 .The hexose monophosphates, fructose 6 P,
 .  .glucose 6 P and glucose 1 P did not release
 .Ins 1,4,5 P at concentrations F0.2 mM. At 2 mM,3
 .30% of aldolase C-bound Ins 1,4,5 P was released3
 .  .by fructose 6 P or glucose 6 P and 50% by
 . w3 xglucose 1 P. 2,3-diphosphoglycerate, released H -
 . Ins 1,4,5 P at mM concentrations EC s108"3 50
.30 mM, ns18 .
 .  . w3 x  . w yxFig. 5. A Comparison of Ins 1,3,4 P -evoked displacement of aldolase C bound H -Ins 1,4,5 P at different Cl at 08C. Data were3 3
 .  . normalized to the maximum amount of Ins 1,4,5 P bound in the absence of Ins 1,3,4 P ns49 for 100 mM KCl; ns15 for 10 mM3 3
.  .  .KCl . B Ins 1,3,4 P displacement at conditions used to simulate the in vivo state. Data from each set were fit to the sigmoidal equation3
 .described in the Section 2 ns17 for 30 mM KCl at 378C . Error bars"SEM.
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[ 2q] [ 2q]3.7. Effect of altering free Mg and free Ca
( )on Ins 1,4,5 P binding to aldolase C3
There was no difference in binding plots obtained
from assays at 30 mM KCl with and without 1 mM
2q  . 2q y9 y4Mg at 08 or 378 ns12 . Ca , 10 to 10 M,
 .had no effect on binding ns21 at 08C and 100 mM
KCl. Because there was no Ca2q effect at 08C we did
not study this at 378C.
( )3.8. Projecting aldolase C bound Ins 1,4,5 P data to3
intact muscle
 .We have assayed for aldolase C Ins 1,4,5 P bind-3
w yxing under conditions which match Cl found previ-i
w xously in smooth muscle, i.e. 30 mEqrl 22,23 , at
378C. Data are plotted in Fig. 6. In this figure bound
 .Ins 1,4,5 P values are given in terms of units that we3
use to quantitate binding in intact muscle i.e.
pmolr100 nmol lipid Pi. To calculate this unit: mol
 .of bound Ins 1,4,5 P per mol aldolase were multi-3 4
plied by moles aldolase in muscle that contained4
 w x.100 nmol lipid Pi data determined previously 9 .
w  . xThis plot defines the relationships of Ins 1,4,5 P3 free
 .and bound Ins 1,4,5 P that are applicable to intact3
muscle.
w  . x  .Fig. 6. Ins 1,4,5 P -bound Ins 1,4,5 P plots obtained under3 free 3
30 mEqrl Cly at 378C. Data are the same as given in Fig. 3, but
 .here units of bound Ins 1,4,5 P were converted to3
pmolr100 nmol lipid Pi, units we used to quantitate the
 . w xIns 1,4,5 P content of intact smooth muscle 1 .3
Table 3
 .Free and bound Ins 1,4,5 P at 378C and 30mM KCl3
 .  .  .Ins 1,4,5 P Ins 1,4,5 P Ins 1,4,5 P3free 3bound 3total
amM pmolr100nmol lipid Pi
0.2 0.99 1.08 2.07
0.4 1.97 1.92 3.89
1.0 4.93 3.55 8.47
a  .   . .Moles Ins 1,4,5 P bound per aldolase Ins 1,4,5 P were3 4 3bound
converted to this unit, as described in the text and in our previous
w x  .publication 1 . Total cellular Ins 1,4,5 P content3
  . .  .Ins 1,4,5 P is the sum of free and bound Ins 1,4,5 P .3total 3
 .Computed values for aldolase C-bound Ins 1,4,5 P3
w  . xfor 0.2, 0.4 and 1.0 mM Ins 1,4,5 P are given in3 free
Table 3. These values indicate that there is consider-
w  . xable binding over this Ins 1,4,5 P range. We3 free
discuss in a later section evidence this range may be
physiological. For the case of agonist-stimulated
w  . xmuscle where Ins 1,4,5 P may reach 1 mM,3 free
3.55 pmolr100 nmol lipid Pi is bound, the partition
 .between free and bound Ins 1,4,5 P is 4.93 and3
3.55 pmolr100 nmol lipid Pi, respectively. At 0.2 and
w  . x0.4 mM Ins 1,4,5 P , 1.08 and 1.92 pmol3 free
 .Ins 1,4,5 P r100 nmol lipid Pi, respectively, are3
computed to be bound to aldolase C.
 .In assessing the significance of Ins 1,4,5 P –al-3
dolase C binding shown in Fig. 6, we have computed
w  . xincreases in cytoplasmic Ins 1,4,5 P that would3 free
 .occur if bound Ins 1,4,5 P were completely and3
rapidly released analogous to displacements which
Fig. 7. Calculated effects of rapidly releasing aldolase C-bound
 . w  . xIns 1,4,5 P on cytoplasmic Ins 1,4,5 P in a homogenous3 3 free
mixed cell. Calculations were performed using data given in
w  . xTable 3. Data were computed for basal Ins 1,4,5 P of 0.2,3 free
0.4 and 1mM.
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 .  . .we evoked in vitro using Ins 1,3,4 P or Fru 1,6 P .3 2
Results of these calculations are shown in Fig. 7. The
 .aldolase C-bound Ins 1,4,5 P store computed from3
w yxour assays, for the condition of 30 mM Cl and
378C, was sufficient at either an unstimulated PTSM
w  . xIns 1,4,5 P of 0.2, 0.4 or 1 mM, if completely3 free
released and not degraded, and mixed in cytosolic
w  . x w yxwater, to double the Ins 1,4,5 P . At 10 mM Cl3 free
w  . xrapid release would triple cytosolic Ins 1,4,5 P . For3
w yx w  . xa Cl of 40 mEqrl, Ins 1,4,5 P after a rapid3 free
w  . xrelease for any Ins 1,4,5 P , would be about 20%3 free
w yxless than computed for a Cl of 30 mEqrl, but still
w  . xcause a large increase in cytoplasmic Ins 1,4,5 P3 free
 .data not shown .
4. Discussion
 .The finding that Ins 1,4,5 P binding to aldolase C3
was sensitive to anion concentrations was not surpris-
ing in view of previous data showing various anions
alter anion transport mechanisms by screening access
wto localized positive charged areas on proteins 24–
x26 . We did not determine why the various anions
 .studied had different effects on Ins 1,4,5 P binding3
to aldolase C. This effect may involve differences
between the free energy of hydration of the bathing
anion and the free energy of interaction of the bathing
w xanions with the positively charged site 25 . Binding
 .of Ins 1,4,5 P to aldolase C was markedly increased3
w yxby decreasing Cl and an additional high affinity
binding site was recruited. Presumably the mecha-
 .nism involved decreased screening of Ins 1,4,5 P so3
that access to the additional binding site was achieved.
Preliminary data using aldolase A mutants suggest
 .Ins 1,4,5 P is bound to positively charged amino3
acids, possibly K146, K107, R42 or R148 C.B.
Baron, R.F. Coburn and D.R. Tolan, unpublished
.data . Data obtained in the present study are consis-
 .tent with anions screening access of Ins 1,4,5 P to3
these binding sites. We know of no previous data
documenting anionic screening of binding of nega-
tively charged ligands to positively charged amino
w yxacids on proteins. Although effects of different Cl
 .on Ins 1,4,5 P binding to PLC-d or to its PH domain3
have not been studied, we note, comparing data
obtained from different laboratories, that the affinity
 .of Ins 1,4,5 P binding was less when measured in3
the presence of 100 mM KCl or NaCl compared to
wvalues obtained when no anions were present 12,14–
x  .17 . Thus, anion screening may influence Ins 1,4,5 P3
binding to other proteins, as well as to aldolase C.
 .Although multiple anions altered Ins 1,4,5 P bind-3
ing to aldolase C, it is likely that only Cly could
w yxexert effects in vivo. The normal intracellular HCO3
was computed from the Henderson Hasselbach equa-
 .tion using P 47 mm Hg and pH 7.0 and found toCO2
be about 5 mEqrl; this concentration had no effect on
 .Ins 1,4,5 P –aldolase C binding at 378C. The concen-3
w 2yxtration of SO in cytoplasm is too low to have an4
 .effect on Ins 1,4,5 P binding to aldolase C. Aldolase3
substrate and by-products markedly decrease aldolase
 .Ins 1,4,5 P binding. We have no information on the3
normal concentrations of these compounds in smooth
muscle cytosol in the unstimulated or agonist-stimu-
lated state, and assume in calculations given below
that concentrations of these compounds are not high
 .enough to alter Ins 1,4,5 P binding. Since monova-3
lent and divalent cations, non-Cly anions and changes
 .in osmolality did not alter Ins 1,4,5 P binding to3
aldolase C at pH 7.0, in our experiments which aimed
at mimicking in vivo conditions, it was considered
not necessary to duplicate the entire cytoplasmic
w yxionic milieu. We aimed at duplicating Cl , tempera-
 .ture and pH, all of which influenced Ins 1,4,5 P3
binding to aldolase C, so that we could project in
vitro binding data to living cells.
w  . xThe Ins 1,4,5 P – aldolase C -bound3 free
 .Ins 1,4,5 P plots that we used to estimate binding in3
 .intact muscle Fig. 6 were obtained from assays
performed at 30 mEqrl Cly at 378C. At electrochem-
w yx ical equilibrium, Cl in PTSM which has a restingi
w x.membrane potential of y65 mV 27 is 10 mEqrl.
w yxSmooth muscle Cl may be higher than the pas-i
sively distributed value; best available data were
w xobtained using the fluorescent indicator MQAE 23 ,
w yxindicating Cl in aortic smooth muscle cells wasi
30 to 40 mEqrl. Because PTSM has a more negative
membrane potential than has been recorded in aortic
 w yxsmooth muscle cells therefore equilibrium Cl isi
.  .lower , we used Ins 1,4,5 P binding data obtained at3
w yxCl of 30 mEqrl in many of our calculations. Al-
dolase is almost entirely bound to PTSM ghosts after
w x w yxisolation 9 , but Cl )40 mEqrl caused some re-
lease of aldolase from ghosts EC s101 mM KCl;50
.C.B. Baron, et al., unpublished data . Therefore,
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w yxCl in intact muscle needs to be -40 mEqrl toi
explain the aldolase bound state in ghosts.
The estimated values of aldolase C-bound
 .Ins 1,4,5 P in intact muscle are dependent on3
w  . xIns 1,4,5 P present in the cytoplasm. Although3 free
w  . xIns 1,4,5 P can not be directly measured in in-3 free
tact muscle, we can estimate values using data ob-
tained in permeabilized muscle. Effects of graded
w  . x 2qincreases in Ins 1,4,5 P on release of SR Ca3 free
were determined in three studies using different per-
w xmeabilized smooth muscles 2,4,5 . Data were consis-
tent in the different studies and indicated threshold
w  . x 2qIns 1,4,5 P for SR Ca release was 0.5 to3 free
0.7 mM, and near maximal Ca2q release occurred at
w  . x)1 mM Ins 1,4,5 P . These values were not very3 free
different from those found in other permeabilized
w x w  . xcells 3 . We have found a similar Ins 1,4,5 P3
 .threshold for Ins 1,4,5 P -induced contractions and3
 .near maximum Ins 1,4,5 P -induced contractions at3
w  . x2 mM Ins 1,4,5 P , in b-escin-permeabilized PTSM3
at 228C R.F. Coburn and C.B. Baron, unpublished
.data . It is recognized that there is a discrepancy
 .between the affinity of Ins 1,4,5 P for the SRrER3
 2qIP -receptor IP R determined using Ca mobiliza-3 3
 . w x 2qtion versus Ins 1,4,5 P binding 3 . EC s for Ca3 50
release are higher than are K s, can not be explainedd
 .by degradation of Ins 1,4,5 P in permeabilized3
preparations, and may be related to threshold binding
to the IP R required for quantal release of Ca2q,3
different IP R isoforms, or other factors. On this3
w  . x 2qbasis, we used threshold Ins 1,4,5 P for Ca3 free
release, rather than K values for binding to thed
w  . xIP R, as a marker for estimating Ins 1,4,5 P in3 3 free
unstimulated and agonist-stimulated muscle. We as-
w  . xsume Ins 1,4,5 P in unstimulated muscle is in3 free
w  . xthe range 40 to 80% of threshold Ins 1,4,5 P for3
Ca2q release, i.e. 0.2 and 0.4 mM. The physiological
w  . xrange for Ins 1,4,5 P in the cytoplasm of intact3 free
muscle then would be from 0.2 to 1.5 mM.
Calculations given in Section 3 suggested that
 .sufficient Ins 1,4,5 P is bound to aldolase C in intact3
w  . xmuscle when Ins 1,4,5 P is 0.2 to 1.0 mM so3 free
that complete release doubled or tripled cytosolic
w  . xIns 1,4,5 P . This finding implies that at very3 free
w  . xlow Ins 1,4,5 P , release could raise cyotoslic3 free
 . xIns 1,4,5 P to threshold for contraction and at3 free
w  . xhigher Ins 1,4,5 P release could augment3 free
 .Ins 1,4,5 P -mediated contractions. These results sug-3
 .gest the magnitude of Ins 1,4,5 P binding to aldolase3
C may have physiological significance. The major
assumptions in the above calculations are that there
are no negatively charged proteins or other com-
pounds in the cytoplasm of intact muscle which alter
 .the Ins 1,4,5 P –aldolase C binding characteristics3
determined in this study, and that aldolase C bound to
 .actin has the same Ins 1,4,5 P binding characteristics3
as non actin-bound aldolase C. Since it is likely that
aldolase C is predominately bound to cytoskeleton
w x w  . x w  . xactin 28 , Ins 1,4,5 P and Ins 1,3,4 P in prox-3 free 3
imity to the cytoskeleton may be pertinent. Some
preliminary data bearing on the second assumption
 .indicate that Ins 1,4,5 P binding to aldolase com-3
plexed to cytoskeletal actin may have a greater affin-
ity than to free aldolase C C.B. Baron, et al., unpub-
.lished data .
We have considered two possible functions of
 .  .Ins 1,4,5 P bound to aldolase C: i that3
 .  .Ins 1,3,4 P -mediated Ins 1,4,5 P release could am-3 3
 .plify effects of Ins 1,4,5 P formed via PLC, and that3
 .release of aldolase C-bound Ins 1,4,5 P might func-3
tion as part of a mechanism whereby PLC-formed
 . 2qIns 1,4,5 P is regenerated and utilized to drive Ca3
 .movements to central sarcoplasmic reticulum SR ,
gap junctions or other cellular Ca2q targets. These
 .postulates depend on the quantity of Ins 1,4,5 P3
bound to aldolase in intact muscle, the cellular loca-
 .tion of this Ins 1,4,5 P store, whether or not release3
w  . xcan substantially alter cytoplasmic Ins 1,4,5 P3 free
 .and the kinetics for Ins 1,4,5 P binding and release.3
 .There is strong evidence that Ins 1,4,5 P formation3
is involved in agonist-evoked smooth muscle force
w xdevelopment and maintained force 6,29,30 .
 .Fig. 8 illustrates how Ins 1,3,4 P evoked release3
 .of aldolase C-bound Ins 1,4,5 P might function in3
the living cell. The model in Fig. 8 is an extension of
 . 2qmodels proposed to explain Ins 1,4,5 P -driven Ca3
waves and Ca2q movements in non-muscle cells
w x w x31–34 and smooth muscle cells 35–37 , a process
dependent on regenerative release of Ca2q from
 . 2qERrSR involving both Ins 1,4,5 P -evoked Ca re-3
lease and Ca2q-induced Ca2q release from ryan-
 .odine-sensitive SR RyR . To this model we add a
 .mechanism for regeneration of Ins 1,4,5 P produced3
by PLC. The classical regenerative Ca2q release
mechanisms is based on bimodal effects of Ca2q on
both IP R and RyR ERrSR. The regenerative3
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 .Fig. 8. Schema for proposed function of Ins 1,4,5 P released3
 .from aldolase C by Ins 1,3,4 P formed by degradation of3
 .Ins 1,4,5 P . The actin cytoskeleton is shown as lines attached to3
 .  .focal adhesion complexes FACs . Aldolase –Ins 1,4,5 P com-4 3
plex is shown as being bound to the actin cytoskeleton. This
 .schema illustrates how Ins 1,4,5 P formed via PLC as a result of3
agonist stimulation might drive Ca2q movements into the cell
 .interior via regenerative release of Ins 1,4,5 P from aldolase–3
 . 2qIns 1,4,5 P , and regenerative release of Ca from IP R and3 3
RyR SR.
 .Ins 1,4,5 P mechanism proposed here, involves dif-3
 .fusion of Ins 1,4,5 P from the sarcolemma where it3
is formed, a portion of which is degraded to
 .  .Ins 1,3,4 P . Ins 1,3,4 P then functions to release3 3
 .  .Ins 1,4,5 P from Ins 1,4,5 P –aldolase C which, in3 3
turn releases Ca2q from IP R containing SR. Because3
peripheral SR is in close proximity to the sarcolemma
w x  .38,39 , regenerative release of Ins 1,4,5 P from3
 .Ins 1,4,5 P –aldolase C is proposed to amplify ef-3
 .fects of Ins 1,4,5 P formed via PLC in evoking3
2q  .Ca release. Diffusion of Ins 1,4,5 P over longer3
distances is required to release Ca2q from central SR
w x40 during agonist stimulation, analogous to models
 .developed by Sneyd and Sanderson for Ins 1,4,5 P3
w xdiffusion to gap junctions 34,41 . Regenerative re-
 .lease of aldolase C bound Ins 1,4,5 P could facilitate3
this.
w  . xThis model could operate if Ins 1,4,5 P is3 free
)0.2 mM and sufficient to cause sufficient binding
 .of Ins 1,4,5 P to aldolase C in unstimulated muscle3
 .that would be available for Ins 1,3,4 P -evoked re-3
w  . xlease. If Ins 1,4,5 P is -0.2 mM in unstimu-3 free
lated muscle, where there may not be significant
 .binding of Ins 1,4,5 P to aldolase C, during agonist3
stimulation, there might be first binding of aldolase C
w  . xas Ins 1,4,5 P increases, which could be re-3 free
w  . xleased as Ins 1,3,4 P increases. Rebinding of3
 .  .Ins 1,4,5 P to aldolase C, after Ins 1,3,4 P -evoked3 3
w  . xrelease, could occur after Ins 1,3,4 P decreases, if3
w  . xIns 1,4,5 P remains greater than 0.2 mM.3 free
This model is dependent on rapid agonist-evoked
w  . x  .increases in Ins 1,3,4 P . Ins 1,3,4 P is essentially3 3
w xundetectable in unstimulated PTSM 1 indicating it
is not constantly formed, or bound in detectable
amounts to aldolase or other compounds under this
condition. In intact muscle, CARB evoked significant
 .increases in Ins 1,3,4 P content, reaching levels at3
w x5 s of about 0.5 mM, and 2.2 mM at about 20 s 1 . In
our in vitro experiments, about 20% of aldolase
 . w  . xbound Ins 1,4,5 P was released at an Ins 1,3,4 P3 3
w yxof about 100 nM, at 30 mEqrl Cl and 378C. That
 .  .we can show Ins 1,3,4 P -evoked Ins 1,4,5 P release3 3
w  . xunder in vitro conditions at an Ins 1,3,4 P consid-3
erably lower than that measured in intact muscle, and
w  . xthat Ins 1,3,4 P are expected to be higher near the3
sarcolemma compared to our mean measured values,
 .supports a function of Ins 1,3,4 P in release of al-3
 .dolase C bound Ins 1,4,5 P .3
5. Conclusion
 .In conclusion, in vitro aldolase C–Ins 1,4,5 P3
binding studies support the presence of physio-
 .logically significant aldolase C–Ins 1,4,5 P binding3
w  . xin unstimulated muscle when Ins 1,4,5 P is as3 free
high as 0.2–0.4 mM, and in stimulated muscle at
w  . xhigher Ins 1,4,5 P .3 free
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